Takeda Pharmaceutical Company Limited (TAK)

NYSE: TAK · Real-Time Price · USD

17.24

+0.42 (2.50%)

At close: Jul 24, 2026, 4:00 PM EDT

17.02

-0.22 (-1.25%)

After-hours: Jul 24, 2026, 7:34 PM EDT

Revenue Breakdown 2

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016	Mar '15 Mar 31, 2015	Mar '14 Mar 31, 2014	Mar '13 Mar 31, 2013
GI Revenue (Post-FY2024 Reporting)	1.41T	1.36T
Rare Diseases Revenue (Post-FY2024 Reporting)	762.70B	752.82B
PDT Revenue (Post-FY2024 Reporting)	1.06T	1.03T
Oncology Revenue (Post-FY2024 Reporting)	580.13B	560.43B
Vaccines Revenue	59.61B	55.41B
Neuroscience Revenue (Post-FY2024 Reporting)	414.34B	565.82B
Other Product Revenue (Post-FY2024 Reporting)	223.96B	257.39B
Revenue (Total)	4.51T	4.58T

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.